Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.

导出原文传递

翻译打印收藏纠错

作者： Taro,Iguchi ^[1] ; Satoshi,Tamada ^[2] ; Minoru,Kato ^[2] ; Sayaka,Yasuda ^[2] ; Yuichi,Machida ^[3] ; Tetsuji,Ohmachi ^[4] ; Keiichi,Ishii ^[5] ; Hiroyuki,Iwata ^[6] ; Shinji,Yamamoto ^[7] ; Tomohiro,Kanamaru ^[8] ; Kazuya,Morimoto ^[9] ; Taro,Hase ^[10] ; Koichiro,Tashiro ^[11] ; Koji,Harimoto ^[12] ; Takashi,Deguchi ^[13] ; Takahisa,Adachi ^[14] ; Katsuki,Iwamoto ^[15] ; Yoshinori,Takegaki ^[16] ; Tatsuya,Nakatani ^[2]

作者单位： Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. taro@msic.med.osaka-cu.ac.jp. ^[1] Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. ^[2] Department of Urology, Yao Municipal Hospital, Yao, Japan. ^[3] Department of Urology, Bell-land General Hospital, Sakai, Japan. ^[4] Department of Urology, Osaka City General Hospital, Osaka, Japan. ^[5] Department of Urology, Itami City Hospital, Itami, Japan. ^[6] Department of Urology, Ikuwakai Memorial Hospital, Osaka, Japan. ^[7] Department of Urology, Yao Tokushukai General Hospital, Yao, Japan. ^[8] Department of Urology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan. ^[9] Department of Urology, Suita Municipal Hospital, Suita, Japan. ^[10] Department of Urology, Meijibashi Hospital, Matsubara, Japan. ^[11] Department of Urology, Fuchu Hospital, Izumi, Japan. ^[12] Department of Urology, PL Hospital, Tondabayashi, Japan. ^[13] Department of Urology, Osaka City Juso Hospital, Osaka, Japan. ^[14] Department of Urology, Ishikiriseiki Hospital, Higashiosaka, Japan. ^[15] Department of Urology, Minamiosaka Hospital, Osaka, Japan. ^[16]

关键词 Castration-resistant prostate cancer Enzalutamide Flutamide Randomized controlled trial